Frontlight ResearchEarly access
SuspendedNo phase
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
Key facts
- Who runs it
- Montefiore Medical Center
- Where
- The Bronx, United StatesSee the site
- Trial code
- Status
- Suspended
- People taking part
- 80 people, planned
- Started
- 29 May 2025
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- GPT-based counseling
- Nutritional Counseling
- Record updated
- 12 June 2026
- Why it stopped
- IRB approval has lapsed, PI has left the institution. PI change planned
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Women aged 18-45
- Diagnosed with GDM in pregnancy
- Able to use a smartphone
- Fluent in English or Spanish
Who cannot take part
- Pre-existing diabetes
- High-risk pregnancies due to other medical conditions
- Inability to consent
- Non-English and/or Non-Spanish speakers
- No smartphone access
Where in United States
- Montefiore Medical CenterThe Bronx, United States
About the trial
What the trial wants to find out
The purpose of this study is to assess whether an AI based counseling service can be beneficial for patients to assist in management of gestational diabetes.
The 2 groups in the trial
- Nutritional Counseling plus AI InterventionTreatment being tested
Treatment: GPT-based counseling and Nutritional Counseling
- Nutritional CounselingExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 12 June 2026